Table 2.
Procedural parameters, safety, and efficacy
| Paroxysmal (n = 113) | Early persistent (n = 86) | Non-early persistent (n = 101) | All (n = 300) | P-value | |
|---|---|---|---|---|---|
| Acute procedural success | 100.0% (113/113) | 97.7% (84/86) | 98.0% (99/101) | 98.7% (296/300) | 0.2036 |
| Procedure time, min (first venous puncture to last catheter removed), mean ± SD (n) | 156.2 ± 48.0 (113) | 157.3 ± 45.9 (86) | 166.5 ± 58.8 (101) | 160.0 ± 51.4 (300) | 0.2892 |
| Mapping timea, min, mean ± SD (n) | 30.2 ± 14.6 (113) | 38.8 ± 16.5 (86) | 41.5 ± 15.1 (98) | 36.4 ± 16.1 (297) | <0.0001 |
| Fluoroscopy time, min, mean ± SD (n) | 10.2 ± 8.9 (113) | 11.6 ± 9.1 (86) | 13.7 ± 11.2 (101) | 11.8 ± 9.9 (300) | 0.0381 |
| Number of cardioversions, mean ± SD (n) | 1.8 ± 1.4 (48) | 1.5 ± 0.9 (63) | 1.9 ± 1.5 (93) | 1.7 ± 1.3 (204) | 0.0931 |
| Serious adverse event rate | 1.8% (2/113) | 2.3% (2/86) | 4.0% (4/101) | 2.7% (8/300) | 0.6689 |
a
Mapping time includes total time collecting maps, including both SR and AF maps.
AF, atrial fibrillation; SD, standard deviation; SR, sinus rhythm.